Topic Hub
23 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 23 of 23 clinical reviews.
MD/PharmD-level guide to diagnosing and correcting ezetimibe non-response: absorption variability, drug interactions, combination strategies, and escalation protocols backed by IMPROVE-IT and primary literature.
Read clinical reviewA clinician-reviewed guide to ezetimibe (Zetia) use after bariatric surgery, covering absorption changes, dosing, drug interactions, lipid outcomes, and post-bariatric cardiovascular risk management with primary-literature citations.
Read clinical reviewA clinician-level review of ezetimibe's effects on kidney function, CKD outcomes, and how IMPROVE-IT and post-hoc renal analyses inform prescribing decisions for patients with or at risk of chronic kidney disease.
Read clinical reviewA week-by-week breakdown of what happens in your first month on ezetimibe (Zetia), including LDL changes, side effects, timelines, and IMPROVE-IT trial data reviewed by the HealthRX medical team.
Read clinical reviewDoes ezetimibe (Zetia) change appetite or food cravings? A physician-reviewed deep dive into the pharmacology, clinical trial data, and patient reports that answer this question.
Read clinical reviewA physician-reviewed guide to ezetimibe (Zetia) use in autoimmune disease, covering drug interactions, immune effects, cardiovascular benefit in lupus and RA, safety data from IMPROVE-IT, and practical dosing guidance.
Read clinical reviewDoes ezetimibe (Zetia) affect bone mineral density or fracture risk? A physician-reviewed, primary-literature analysis of every major trial and mechanism study.
Read clinical reviewA physician-level review of the ezetimibe (Zetia) cancer risk signal, covering IMPROVE-IT data, post-marketing pharmacovigilance, NPC1L1 biology, and current ACC/AHA guideline recommendations.
Read clinical reviewA deep clinical review of ezetimibe's long-term cardiovascular impact, grounded in IMPROVE-IT, SHARP, and current ACC/AHA guidelines. Learn what the trial data show, who benefits most, and how to use ezetimibe in practice.
Read clinical reviewA clinician-level review of ezetimibe (Zetia) and cognition, covering IMPROVE-IT data, FDA post-market surveillance, proposed mechanisms, and how to counsel patients asking about memory or cognitive side effects.
Read clinical reviewA physician-reviewed comparison of compounded ezetimibe versus branded Zetia, covering bioequivalence evidence, regulatory status, IMPROVE-IT trial data, and how to choose the right formulation for LDL-C lowering.
Read clinical reviewA GRADE-graded review of ezetimibe (Zetia) evidence covering IMPROVE-IT, SHARP, and current ACC/AHA guideline recommendations, with dose, safety, and combination-therapy data for clinicians.
Read clinical reviewA clinical deep-dive into ezetimibe (Zetia) and its documented effects on hair and skin, including alopecia, rash, and urticaria reports from postmarketing data, IMPROVE-IT trial findings, and FDA labeling.
Read clinical reviewA clinician-level review of ezetimibe (Zetia) and liver function: ALT/AST elevations, hepatotoxicity risk, IMPROVE-IT data, and monitoring guidance for patients on statin combinations.
Read clinical reviewA physician-reviewed deep dive into ezetimibe (Zetia) and its effects on mental health, mood, depression, and cognitive function. Covers IMPROVE-IT data, pharmacology, and clinical guidance.
Read clinical reviewA clinical deep-dive into how ezetimibe (Zetia) is absorbed, metabolized, and excreted, and what the current evidence says about its effects on energy expenditure, thermogenesis, and metabolic rate.
Read clinical reviewA physician-level review of ezetimibe (Zetia) microdosing protocols, covering the pharmacology, IMPROVE-IT trial data, guideline recommendations, and whether sub-standard dosing has clinical support.
Read clinical reviewA physician-reviewed, evidence-based guide to using ezetimibe (Zetia) as a muscle-sparing lipid-lowering strategy, with primary-literature citations from IMPROVE-IT, ACC/AHA guidelines, and statin myopathy trials.
Read clinical reviewA comprehensive MD/PharmD-level guide to ezetimibe (Zetia) pre-operative management, hold timing, cardiovascular risk bridging, and resumption protocols, with primary-literature citations throughout.
Read clinical reviewDoes stopping ezetimibe (Zetia) cause a rebound spike in LDL? Learn what the clinical evidence shows, how fast cholesterol rises, and what your doctor should do if you discontinue.
Read clinical reviewA physician-reviewed guide to ezetimibe (Zetia) seasonal use considerations, including how cold weather, diet shifts, adherence patterns, and drug interactions change across seasons. Includes IMPROVE-IT trial data, ACC/AHA guideline references, and clinical dosing guidance.
Read clinical reviewA clinical deep-dive into whether ezetimibe (Zetia) affects sleep architecture, polysomnography findings, comparisons with statins, and what the current evidence says for patients on lipid-lowering therapy.
Read clinical reviewMD/PharmD-level guidance on ezetimibe (Zetia) dosing during travel, timezone crossings, missed-dose management, and drug interactions at altitude or in transit. Includes IMPROVE-IT trial context and ACC/AHA guideline references.
Read clinical review